AS101 is primarily investigated for its immunomodulatory and anti-cancer properties. It enhances the activity of the immune system by stimulating dendritic cells and promoting T-cell responses, making it a candidate for use in cancer immunotherapy. Research shows it can inhibit tumor growth in preclinical models, particularly by blocking the IL-10 signaling pathway, which tumors often exploit to suppress immune detection. AS101 has also demonstrated neuroprotective effects and is being explored in the context of neurodegenerative diseases. Additionally, it exhibits antiviral activity, with studies suggesting potential in treating viral infections such as HIV and Zika virus. Its ability to modulate oxidative stress and reduce inflammation further supports its therapeutic development in autoimmune and inflammatory conditions.